Reporting on ASH 2025, Dr Jamile Shammo highlights long-term follow-up data for established paroxysmal nocturnal ...

The third generation EGFR TKI targets EGFR mutant NSCLC, showing improved progression free survival and fewer adverse events ...

Kim Allan Williams, MD, discusses how the ACC’s endorsement of front-of-package nutrition labeling may change the ...

Europe’s 2040 tobacco-free goal faces hurdles from new products and funding gaps. Success depends on integrating cessation ...

The growing evidence that inflammation is a primary cause of aging skin supports ongoing efforts to study targeted ...

Patients with high volumes of fat tissue around the heart may experience greater myocardial injury after acute myocardial ...

So far, “the only established risk factors for prostate cancer are advancing age, African ancestry, and a family history of ...

Scotland’s NHS can now offer givinostat to ambulant children with Duchenne muscular dystrophy, marking a step forward in care ...

Lower urinary tract symptoms are not associated with an increased risk for high-grade prostate cancer, rendering biopsies and ...

Treatment with omalizumab offers modest protection from allergic reactions to individuals with multiple food allergies, and ...

Use of the antifibrinolytic medication ‘narrowly exceeded’ noninferiority in VTE risk compared with placebo in noncardiac ...

A young woman treated for suspected methaemoglobinaemia instead experiences worsening haemolysis that reveals a previously ...